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abstract
 
The bacterial toxin colicin Ia forms voltage-gated channels in planar lipid bilayers. The toxin consists
of three domains, with the carboxy-terminal domain (C-domain) responsible for channel formation. The C-domain
contributes four membrane-spanning segments and a 68-residue translocated segment to the open channel,
whereas the upstream domains and the amino-terminal end of the C-domain stay on the cis side of the membrane.
The isolated C-domain, lacking the two upstream domains, also forms channels; however, the amino terminus and
one of the normally membrane-spanning segments can move across the membrane. (This can be observed as a
 
drop in single-channel conductance.) In longer carboxy-terminal fragments of colicin Ia that include 
 
 
 
169 residues
upstream from the C-domain, the entire upstream region is translocated. Presumably, a portion of the C-domain
 
creates a pathway for the polar upstream region to move through the membrane. To determine the size of
this translocation pathway, we have attached “molecular stoppers,” small disulﬁde-bonded polypeptides, to the
amino terminus of the C-domain, and determined whether they could be translocated. We have found that the
translocation rate is strongly voltage dependent, and that at voltages 
 
 
 
90 mV, even a 26-Å stopper is translocated.
Upon reduction of their disulﬁde bonds, all of the stoppers are easily translocated, indicating that it is the folded
structure, rather than some aspect of the primary sequence, that slows translocation of the stoppers. Thus, the
pathway for translocation is 
 
 
 
26 Å in diameter, or can stretch to this value. This is large enough for an 
 
 
 
-helical
hairpin to ﬁt through.
 
key words:
 
 
 
-conotoxin • apamin • charybdotoxin • disulﬁdes • molecular stoppers
 
INTRODUCTION
 
Colicin Ia is a 626-residue bactericidal protein that
forms voltage-gated channels in the inner membrane
of sensitive 
 
E. coli
 
 bacteria and in planar lipid bilayers.
The protein consists of three domains (Wiener et al.,
1997), with the 10–
 
 
 
-helix colicin Ia carboxy-terminal
domain
 
 
 
(C-domain)* (residues 451–626) forming the
lethal channel. (For a general review of channel-forming
colicins and colicin Ia in particular, see Jakes et al.,
1999). Channel formation by whole colicin Ia can be
conceptually divided into two steps: (1) voltage-inde-
pendent insertion of the hydrophobic hairpin formed
by helices 8 and 9 (Kienker et al., 1997) and (2) volt-
age-dependent insertion of portions of helix 1 and heli-
ces 6–7 (Qiu et al., 1996). Associated with the voltage-
dependent step is the translocation across the mem-
brane of 
 
 
 
68 residues corresponding to helices 2–5
(Qiu et al., 1996). The open channel formed by whole
colicin Ia thus consists of four membrane-spanning seg-
ments,
 
1
 
 with the upstream T and R domains remaining
on the cis side (the side to which the colicin was added)
(Fig. 1 C).
Channel formation by the isolated C-domain, or by
carboxy-terminal fragments containing as many as 345
 
residues (residues 282–626), is similar to channel for-
mation by whole colicin, except that the portion of
helix 1 (H1) that was in the membrane, and everything
upstream from it, is also translocated across the mem-
brane, resulting in a small-conductance channel having
only three transmembrane segments (Fig. 1 E) (Kienker
et al., 2000). On the way to this small-conductance
state, the channel initially opens to a state of relatively
normal conductance (Kienker et al., 2000) (Fig. 1 B).
 
We have good reason to believe (see 
 
results
 
) that
the initial normal-conductance channel corresponds to
the channel with four transmembrane segments, like
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More precisely, four membrane-spanning segments are contributed
by each colicin Ia molecule in the channel. Surprisingly, it appears
that there is only one colicin molecule per channel. (See Jakes et al.,
1999, for references.)T
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that formed by the whole colicin (Fig. 1, compare C
with D). The transition to the small-conductance chan-
nel marks the passage of the fourth segment (H1) (and
everything upstream of it) across the membrane, and
thus the conversion to a channel with only three trans-
membrane segments (Fig. 1 E).
What is the nature of the translocation passageway
that the colicin creates for the fourth segment to cross
the membrane? We know that this passageway allows
the movement through it of the very polar and highly
charged sequences that make up the upstream parts of
colicin Ia carboxy-terminal fragments (Kienker et al.,
2000), suggesting that it provides a high-dielectric–con-
stant milieu, but how wide is it? We previously showed
that if the amino terminus of the C-domain is biotin-
ylated and then preincubated with streptavidin, the re-
sulting channels open to the normal-conductance state
and remain there, failing to drop to the small-conduc-
tance state typical of C-domain channels (Kienker et
al., 2000). Presumably, streptavidin holds the amino
terminus on the cis side and prevents its translocation
across the membrane. Thus, we know from these ear-
lier experiments that the translocation pathway for the
amino terminus is not wide enough to accommodate
the 61-Å-diameter streptavidin tetramer. Does the pep-
tide chain have to unfold to ﬁt through it, or can its sec-
ondary structure, and even its tertiary structure, be pre-
 
served during its passage? To address these questions, we
attached a series of molecular “stoppers” to the amino ter-
minus of the C-domain and determined how large a stop-
per could still cross the membrane. The stoppers consisted
of peptides locked into a more or less ﬁxed conformation
by one or more disulﬁde bonds (see 
 
materials and
methods
 
). We reasoned that if the channel passed from
the normal-conductance to the small-conductance state
(as in Fig. 1 B), then the stopper had passed through,
whereas if it remained in the normal-conductance state (as
in Fig. 1 A), the stopper was too large to pass through. Us-
ing this approach we determined that the passageway can
be at least 26 Å wide at its narrowest point.
 
MATERIALS AND METHODS
 
Construction of the Stoppers
 
Four separate molecular stopper constructs were prepared, all
with the stopper attached near the amino-terminal end of the co-
licin Ia carboxy-terminal fragment 438–626 (called CT-M in Kien-
ker et al., 2000). pKSJ155 has residues 438–626 of colicin Ia in-
serted downstream of the 6 histidine tag (His
 
6
 
-tag) sequence in
the Novagen vector pET-15b. The three smaller stoppers were in-
serted genetically, by site-directed mutagenesis, so that their se-
quences were inserted immediately upstream of the beginning of
the colicin sequence, before either residue 438 or 439. All of
the insertions were made using Stratagene’s QuikChange site-
directed mutagenesis kit. The largest stopper, charybdotoxin
Figure 1. Comparison of sin-
gle channels formed by whole
colicin Ia and its carboxy-
terminal domain (Kienker et
al., 2000). (A) A whole colicin
Ia channel opened at  50
mV with its characteristic, rel-
atively high conductance (39
pS) and, as is typical at this
voltage, stayed at this level.
(B) A C-domain channel (res-
idues 438–626) opened at
 50 mV with a comparable
conductance (44 pS), but
then dropped to a state of
smaller conductance (7 pS).
(C) Schematic model of the
whole colicin Ia channel in its
open state, with four mem-
brane-spanning segments.
The 10  -helices of the
C-domain are designated
H1–H10; T/R represents the
upstream T and R domains.
The part of H1 spanning the
membrane is roughly from
residues 451–467. (D) Model of the C-domain channel in its transient, higher conductance state, also with four membrane-spanning
segments. (E) Model of the C-domain channel in its small-conductance open state, with only three membrane-spanning segments,
and helix H1 translocated across the membrane. The white bar in A indicates the open channel state that is diagrammed in C. In B, the
black bar indicates when the channel is in the transient open state of D, and the gray bar indicates when it is in the small-conductance
open state of E. The zero-current level in A and B is labeled 0 pA. There are two small-conductance channels already open at the beginning
of the record in B. The solution on both sides of the membrane for A and B was 1 M KCl, 5 mM CaCl2, 1 mM EDTA, 20 mM MES, pH 6.2.T
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(CTX), was attached chemically to the side chain of a cysteine in-
troduced at residue 439.
Peptide U,
,
which has a single disulﬁde bond, was inserted before residue
439 of colicin Ia, using the mutagenic oligonucleotide 5
 
 
 
-GCG-
GCAGCCATATGCTCGAC
 
TGTGGAAGTGGTGACGGAAGCG-
GCTGC
 
GAGAAAAGAAAACAGGATGAACTGAAGGC
 
-3
 
 
 
 and its re-
verse complement. The inserted sequence is in boldfaced type,
the upstream sequence from the pET-15b vector is in standard
type, and colicin sequence beginning with residue 439 is in
italics.
The twelve amino acids of 
 
 
 
-conotoxin ImI, which has two dis-
ulﬁde bonds,
(Maslennikov et al., 1999), were inserted in a single round of mu-
tagenesis before residue 438 of the colicin Ia sequence in
pKSJ155. The mutagenic oligonucleotides used for the inser-
tion were 5
 
 
 
-GCAGCCATATGCTC
 
GGCTGTTGTTCCGACCCG-
CGCTGTGCTTGGCGTTGT
 
GAGGAGAAAAGAAAACAGGATG
 
-
3
 
  
 
and its reverse complement. Vector sequence is in standard
type, the inserted sequence is in boldfaced type, and colicin Ia se-
quence is in italics.
The eighteen residues of apamin, which has two disulﬁde
bonds,
(Pease and Wemmer, 1988), were inserted before residue 438 of
pKSJ155 in two steps of mutagenesis, ﬁrst inserting the last nine
residues, and then inserting the ﬁrst nine residues immediately be-
fore the ﬁrst insertion. The mutagenic oligonucleotides for the
ﬁrst round of insertions were 5
 
 
 
-GCGCGGCAGCCATATGCTC
 
CT-
GTGCGCCCGTCGCTGCCAGCAGCAT
 
GAGGAGAAAAGAAA-
ACAGGATGAACTGAAGG
 
-3
 
 
 
 and its reverse complement. The mu-
tagenic oligonucleotides used for the subsequent round were 5
 
 
 
-
GCGCGGCAGCCATATGCTCTGCAACTGCAAAGCGCCGGAAA-
CCGCG
 
CTGTGCGCCCGTCGCTGC
 
-3
 
 
 
 and its reverse comple-
ment. pET-15b sequences are shown in standard type, apamin in-
serted sequences are in boldfaced type and in underlined type, and
colicin sequence is in italics. The products of all mutagenesis reac-
tions were sequenced to conﬁrm the correct insertion sequences.
The proteins were expressed and puriﬁed from the plasmids
bearing the insertions in BL21 (DE3) cells induced with 1 mM
isopropyl-
 
 
 
-D-thiogalactoside (Labscientiﬁc, Inc.). Cultures of
400–500 ml were grown and the proteins were puriﬁed on His-
Bind (Novagen) nickel afﬁnity columns, as described previously
(Kienker et al., 2000). The yields were 
 
 
 
4 mg for the peptide U
insertion protein, 16 mg for the 
 
 
 
-conotoxin insertion protein,
and 11 mg for the protein with apamin inserted.
The His
 
6
 
-tag was removed from each of the three proteins con-
taining genetically inserted stoppers by incubating the protein
with thrombin (Novagen) for 5 h at room temperature in 20 mM
Tris-Cl, pH 8.5, 150 mM NaCl. The thrombin/protein ratio was
1:1,000 by weight. The reaction was stopped with 1 mM PMSF. In
one set of experiments with peptide U (see RESULTS), the His
 
6
 
-
tag was not removed.
CTX, with 37 amino acids, has the sequence H-PyrPheThr-
AsnValSerCys7ThrThrSerLysGluCys13TrpSerValCys17GlnArgLeu-
HisAsn-ThrSerArgGlyLysCys
 
28
 
MetAsnLysLysCys
 
33
 
ArgCys
 
35
 
Tyr-
Ser, with three disulﬁde bonds, between cysteine residues 7–28,
13–33, and 17–35 (Bontems et al., 1992). CTX was genetically
 
modiﬁed and chemically attached to colicin Ia residue 439,
which had been mutated from glutamic acid to cysteine in
pKSJ155, to yield pKSJ156 (Kienker et al., 2000), as follows.
Three of the four lysines of CTX were mutated (K11Q/K31R/
K32R) to generate a toxin bearing a single amino group (K27).
Mutation, expression, amino-terminal pyroglutamate (Pyr)
blocking, and puriﬁcation of this toxin were as previously re-
ported (Stampe et al., 1994). N-succinimidyl 3-maleimidopro-
pionate (SMP) was synthesized as described (Nielsen and Buch-
ardt, 1991) and was used to introduce maleimide functionality to
the toxin via chemical modiﬁcation of K27. Speciﬁcally, 2 ml of a
solution containing 1.7 mM SMP in acetonitrile were added to a
10-ml solution containing 50 
 
 
 
M CTX and 50 mM sodium phos-
phate buffer, pH 7.2. The resultant solution was stirred at room
temperature for 30 min and then centrifuged under reduced
pressure for 
 
 
 
3 min to decrease the acetonitrile concentration
to 5–10%. The maleimido-CTX was puriﬁed using a C18 column
(YMC, Inc.) with a linear, water–acetonitrile gradient (Waters
HPLC system, Waters Corp.), and assayed on a Mariner electro-
spray/TOF mass spectrometer (PE Biosystems/Perkin Elmer).
Eluates from several preparative HPLC runs were pooled, evapo-
rated under reduced pressure to a ﬁnal volume of 
 
 
 
5 ml, and ad-
justed to pH 7.2 via the addition of sodium phosphate to a con-
centration of 25 mM. The sample was frozen and lyophilized to a
volume of 
 
 
 
0.5 ml, and the volume was then increased to 1.8 ml
by the addition of sodium phosphate buffer. The composition of
this ﬁnal solution was 150 
 
 
 
M maleimido-CTX in 150 mM so-
dium phosphate buffer. Puriﬁed material was 
 
 
 
95% pure as
judged by reinjection on an analytic C18 column while monitor-
ing absorbance at 280 nm.
The His
 
6
 
-tag was removed from E439C colicin Ia C-domain
protein by digestion with thrombin, using the same conditions as
described above, except that the thrombin/protein ratio was
1:2,000 by weight. After the reaction was stopped with PMSF, the
protein was reduced by adding 1 M DTT to a ﬁnal concentration
of 20 mM and incubating 1 h at room temperature. DTT was re-
moved by dialysis, ﬁrst against degassed 10 mM MES, pH 6.0, 2
mM EDTA, 0.1 mM tris (2-carboxyethyl)phosphine hydrochlo-
ride (TCEP) (Pierce Chemical Co.), and then against the same
degassed buffer without EDTA. The reduced, dialyzed protein
was transferred to argon-ﬁlled tubes and stored under argon at
 
 
 
80
 
 
 
C. 7.5 
 
 
 
g of this protein in 3 
 
 
 
l (3 
 
 
 
 10
 
 
 
10
 
 moles) was added
to 37 
 
 
 
l of maleimido-CTX (5.5 
 
 
 
 10
 
 
 
9
 
 moles) in 150 mM so-
dium phosphate, pH 7.2, an 
 
 
 
18-fold excess of the CTX over co-
licin peptide. The reaction was incubated for 30 min at 30
 
 
 
C and
then stopped by addition of excess 
 
 
 
-mercaptoethanol. Approxi-
mately 80–90% of the colicin peptide was judged to have reacted
with the maleimido-CTX by analysis on a 15% polyacrylamide-
SDS gel. Wild-type colicin Ia C-domain was treated with throm-
bin, reduced, dialyzed, and reacted with maleimido-CTX in
exactly the same way as the E439C mutant, as a control for non-
speciﬁc reaction of the maleimido-CTX with residues other than
cysteine. There was no apparent reaction of the wild-type C-domain
peptide with the reagent. The CTX moiety attached to colicin
(CTX–C-domain) was unfolded by adding 1/25 volume of 1.5 M
Tris-Cl, pH 8.8, to raise the pH to 
 
 
 
8.0, and making the protein
solution 10 mM in DTT. The protein was then heated at 70
 
 
 
C for
10 min and quenched on ice (Naini et al., 1996).
 
Assessment of Stopper Folding
 
The proteins containing the three smaller stoppers had a ten-
dency to dimerize or multimerize via their multiple cysteine sulf-
hydryl groups. Keeping the proteins at concentrations below 
 
 
 
1
mg/ml throughout the puriﬁcation procedure reduced the ratio
of multimers to monomers. We were also concerned that thereT
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might be improperly folded stoppers that had a free cysteine. To
assay for free cysteines, the proteins were reacted with 
 
N-
 
[6
 
 
 
-
(biotinamido) hexyl]-3
 
 
 
-(2
 
 
 
-pyridyldithio) propionamide (biotin-
HPDP) (Pierce Chemical Co.) without prior reduction (Qiu et
al., 1996). Any free cysteines were thus biotinylated, and could be
detected by a gel-shift assay with streptavidin (Qiu et al., 1994).
Both the peptide U and 
 
 
 
-conotoxin stoppers were judged to
have measurable free cysteine by this method, 
 
 
 
10% of peptide
U and nearly 50% of 
 
 
 
-conotoxin (unpublished data). The bio-
tinylated protein was then removed from the preparation by
chromatography on monomeric avidin, as described previously
(Qiu et al., 1996). This procedure appeared to remove any pro-
tein that had a free cysteine that had reacted with biotin-HPDP,
as measured by gel-shift by streptavidin (Qiu et al., 1994). The
preparations still contained a small amount of dimers and higher
multimers, as assessed by SDS-polyacrylamide gel.
 
Puriﬁcation of Streptavidin- and Avidin-bound C-domain
 
We prepared and puriﬁed streptavidin-bound C-domain as fol-
lows. The mutant E439C of C-domain (residues 438–626) was
biotinylated and had its His
 
6
 
-tag removed as previously described
(Kienker et al., 2000); 15 
 
 
 
g of this protein was incubated with
800 
 
 
 
g of streptavidin (an 18-fold molar excess of streptavidin
tetramer) at room temperature for 15 min in a total volume of
120 
 
 
 
l. The mixture was centrifuged to remove any particulates,
applied to a BioSil 250 sizing column (Bio-Rad Laboratories),
and eluted in 100 mM NaCl, 50 mM HEPES, pH 7.4. The absor-
bance at 280 nm was monitored. Three peaks were seen: ﬁrst a
small peak containing streptavidin-bound C-domain, then a large
streptavidin peak, and ﬁnally a small peak containing unbound
C-domain. The ﬁrst two peaks were also observed with streptavi-
din alone; apparently the commercial streptavidin contains some
high molecular weight material that happens to run together
with the streptavidin-bound C-domain.
The puriﬁcation of avidin-bound C-domain was similar, except that
avidin was incubated with biotinylated C-domain for 60 min. Avidin
alone had only one broad peak. No peak was visible for avidin-bound
C-domain, so we used a fraction from the leading edge of the avidin peak.
 
Estimation of Stopper Diameters
 
Three-dimensional structures of peptide U (with its two cys-
teine residues forming a disulﬁde bond) were calculated by T.
Newman using an AMBER force ﬁeld (Cornell et al., 1995),
with water treated as a continuum solvent. The 16 lowest-energy
structures were displayed as space-ﬁlling models in RasMol
(v2.6-ucb), and rotated by eye to minimize the diameter of the
two-dimensional projection on the computer screen. This mini-
mal cross-sectional diameter is deﬁned by the smallest circle
that can be drawn around the image of the molecule (Fig. 2 A).
The peptide U model structure with the 4th-lowest energy had
the smallest diameter, 12.3 Å.
Structures of 
 
 
 
-conotoxin ImI were obtained from the Protein
Data Bank (Berman et al., 2000) ﬁles 1IMI (Maslennikov et al.,
1999), 1IM1 (Rogers et al., 1999), 1CNL (Gehrmann et al., 1999),
and 1G2G (Lamthanh et al., 1999), and inspected as above. The
smallest diameter, 15.2 Å, was found in 1CNL, model 7 (Fig. 2 B).
Six sets of coordinates for the structure of apamin were kindly
provided by D.E. Wemmer (Pease and Wemmer, 1988). The
structure in model 6 had the smallest diameter, 17.7 Å. Because
this model did not include hydrogen atoms, we added 1 Å to get
18.7 Å (Fig. 2 C).
The CTX structures came from Protein Data Bank ﬁle 2CRD
(Bontems et al., 1992); the smallest diameter was 26.4 Å in model
9 (Fig. 2 D). The structures of the streptavidin tetramer bound to
two or four biotin molecules were from ﬁles 1SWD and 1SWE, re-
spectively (Freitag et al., 1997). Both structures had a minimal di-
ameter of 59.7 Å; adding 1 Å to account for the missing hydrogen
atoms gives 60.7 Å (Fig. 2 E).
Of course, the stopper peptides are somewhat ﬂexible, so they
may be able to assume conformations with a smaller diameter
than those we have estimated above. For instance, allowing the
projecting Arg and Lys side chains to bend out of the way might
reduce the CTX diameter by a few angstroms. However, the rea-
son we chose to use stoppers with a disulﬁde-bonded core was
that we expected their dimensions would be reasonably well de-
ﬁned. This expectation was supported by inspection of the avail-
able structures. The standard deviation of the minimal diameter
Figure 2. Structures of the stopper
peptides. Each stopper is viewed along
its longest axis, so that the smallest
cross-sections are shown. The cross-
sectional diameter, deﬁned by the cir-
cumscribed circle (dashed line) is given
for each stopper. (A) Peptide U, 12 Å.
(B)  -Conotoxin ImI, 15 Å. (C) Apamin,
19 Å. (D) CTX, 26 Å. (E) Streptavidin
tetramer bound to biotin, 61 Å. Details
about the stopper structures and the esti-
mation of their diameters are given in
materials and methods. The pictures
of animals in this and subsequent ﬁg-
ures are provided to aid in matching
each record with the corresponding
stopper. In A–D, respectively, the ani-
mal represents the natural source of
the stopper: unicorn–peptide U; cone
snail– -conotoxin; honeybee–apamin;
scorpion–CTX.T
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was less than or equal to 1.0 Å for the calculated peptide U
structures, the apamin and CTX NMR structures, and the two
streptavidin crystal structures. This was also true for the struc-
tures in each of the 
 
 
 
-conotoxin ﬁles; however, the mean diame-
ter varied by up to 3.2 Å among these ﬁles. Note that our CTX
stopper contains three mutations, whereas the structure in Fig.
2 D is wild-type CTX.
Visual inspection of the stopper structures using RasMol
showed them to be quite polar molecules, with no signiﬁcant hy-
drophobic patches on the surface. Thus, these stoppers are well
suited for probing a passageway that we know can translocate
parts of the very polar colicin Ia protein.
 
Planar Bilayer Experiments
 
Folded planar lipid (asolectin) bilayer membranes (100–150 
 
 
 
m
in diameter) were formed at room temperature as previously de-
scribed (Kienker et al., 2000). The membrane separated two 1-ml
compartments, each containing a solution of 100 mM KCl, 5 mM
CaCl
 
2
 
, 1 mM EDTA, 20 mM MES, pH 6.2. For single-channel ex-
periments, 1 M KCl was used. The voltage-clamp recording setup
was as described previously (Kienker et al., 2000). Voltages are
given as the potential of the cis compartment, deﬁned as the side
to which colicin Ia C-domain was added, with respect to that of
the opposite trans compartment. Streptavidin and avidin were
obtained from Calbiochem. The antibody to the His
 
6
 
-tag was
mouse Penta-His mAb (QIAGEN), mouse anti–
 
 
 
-galactosidase
mAb was from Promega, rabbit anti-CTX polyclonal antibody was
from Alomone Labs, and rabbit anti-HA.11 polyclonal antibody
was from Covance.
 
Analysis of Normal-State Dwell Times
 
C-domain channels initially open to a state of “normal” conduc-
tance (like that of whole colicin Ia); they may subsequently make
an abrupt transition to a small-conductance open state (Fig. 1 B).
This transition is closely associated with the translocation of the
amino terminus of the C-domain across the membrane to the
trans side (Fig. 1 E). Thus, the dwell time in the normal state
contains information about how readily the amino-terminal end
is translocated. As we shall see, similar conductance transitions
can be observed in channels formed by C-domain with an amino-
terminal stopper peptide. In this case, the dwell time in the nor-
mal state reﬂects the rate of stopper translocation.
We show the distribution of normal-state dwell times in a sur-
vival plot, in which the ordinate is the percentage of events ob-
served with a dwell time greater than the time 
 
t
 
 plotted on the ab-
scissa. For example, if four channels made transitions in times 
 
t
 
1
 
,
 
t
 
2
 
, 
 
t
 
3
 
, and 
 
t
 
4
 
, ordered from shortest to longest, then we would plot
symbols at (0, 100%), (
 
t
 
1
 
, 75%), (
 
t
 
2
 
, 50%), (
 
t
 
3
 
, 25%), and (
 
t
 
4
 
,
0%). As another example, if two channels made transitions in
times 
 
t
 
1
 
 and 
 
t
 
2
 
, and the other two channels did not make a transi-
tion within the maximum time 
 
T allowed, then we would plot
symbols at (0, 100%), (t1, 75%), (t2, 50%), and (T, 50%). The
small-conductance channel can be returned to the original
closed state by negative voltages (Kienker et al., 2000); thus, we
could make several measurements of the normal-state dwell time
from an individual channel. In general, however, each survival
plot contains lifetimes of several different channels, each mea-
sured multiple times.
If all the channels are identical and the normal state is a single
Markov state, then the normal-state lifetimes should be distrib-
uted as a single decaying exponential. In reality, a single expo-
nential function is generally inadequate to ﬁt the survival plots
for C-domain with or without a stopper (see below). Thus, we
usually ﬁt the survival plots using a sum of two exponential com-
ponents: A exp( t/ 1)   (100%   A) exp( t/ 2).
RESULTS
Validity of the Translocation Assay
The conclusions regarding the translocation pathway
that are derived from the results to follow rest on the
evidence that the transition of C-domain channels from
a normal-conductance state (similar to that of channels
formed by whole colicin Ia) to a small-conductance
state (Fig. 1 B) represents the translocation of the
amino terminus from the cis to the trans side of the
membrane, and thus the conversion from a channel
with four transmembrane segments to one with only
three (Fig. 1, D and E). It is therefore appropriate, be-
fore proceeding, to review this evidence. We have
shown previously that in channels formed by whole co-
licin Ia, the amino-terminal region is on the cis side of
the membrane, and that there are four membrane-
spanning segments, with the most upstream segment
formed by part of helix 1 (Qiu et al., 1996). In channels
formed by the isolated C-domain, on the other hand,
the amino terminus ends up on the trans side, leaving
only three membrane-spanning segments (Fig. 1 E)
(Kienker et al., 2000). Initially the C-domain channel
opens to a conductance similar to that of the whole co-
licin Ia channel (Fig. 1 B), consistent with its having
four membrane-spanning segments. It drops to a con-
ductance that is the same as that generated in whole co-
licin Ia channels when trypsin added on the trans side
of the membrane cleaves the colicin in the loop be-
tween helices 2 and 3, thereby leaving only three mem-
brane-spanning segments (Kienker et al., 2000).
All of this is consistent with the transition from the
normal to the small conductance level being a conse-
quence of the movement of the membrane-spanning
portion of helix 1, along with its amino terminus,
across the membrane to the trans side. Conﬁrming this
interpretation is the fact that when the amino terminus
of the C-domain is held on the cis side of the mem-
brane by streptavidin, the transition to the small con-
ductance level does not occur; i.e., when the upstream
membrane-spanning segment formed by part of helix 1
cannot move across the membrane, the conductance
stays at the higher level (Kienker et al., 2000). These
observations convinced us that, for a C-domain protein
with a stopper appended to its amino terminus, the
presence or absence of transitions from a normal to
small channel conductance state would provide a way
of knowing whether the stopper had traversed the
membrane.
Direct Demonstration of Stopper Translocation
With two of the stoppers, peptide U and CTX, we di-
rectly demonstrated, without having to rely on our inter-
pretation of the conductance transitions, that they could
be translocated across the membrane. In experimentsT
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166 Sizing a Protein Translocation Pathway
with the peptide U stopper, we found that the amino ter-
minal His6-tag (which had not been removed for these
experiments) was accessible to anti–His6-tag antibody
in the trans compartment. Thus, although channels
formed by this construct showed the normal gating pat-
tern of turning on at positive voltages and off at negative
voltages, a new conductance pattern developed when
mouse anti–His6-tag mAb was added to the trans com-
partment, in which there was a rise in conductance at
negative voltages (Fig. 3). (This was observed in n  
3 separate experiments.) The reason why channels
formed by the isolated C-domain appear to reverse ori-
entation when bound by trans anti–His6-tag antibody or
trans streptavidin (if they are biotinylated near the
amino terminus) is not clear, but it is a phenomenon we
have reported previously for several C-domain constructs
(Kienker et al., 2000). Whatever the mechanism, the im-
portant point in this instance is that the amino terminal
His6-tag, along with the peptide U stopper, has been
translocated across the membrane. In control experi-
Figure 3. The effect of trans anti–
His6-tag antibody on channels formed by
C-domain with a peptide U stopper and
an amino-terminal His6-tag. Before the
start of the record, 56 ng of C-domain
with a peptide U stopper and an amino-
terminal His6-tag were added to the cis
compartment. Normal gating was ob-
served, with the conductance turning
on at  70 mV and off at voltages from
 50 to  100 mV. During the 2-min
break in the record, 2  g of anti–His6-
tag antibody were added to the trans
compartment. A new conductance rap-
idly developed that turned on at nega-
tive voltages ( 100 or  80 mV) and off
at 0 mV or positive voltages—the re-
verse of the normal voltage depen-
dence. This demonstrates that the
amino-terminal His6-tag was accessible
to trans antibody, and indicates that the peptide U stopper is translocated to the trans side. The solution on both sides of the membrane
was 100 mM KCl, 5 mM CaCl2, 1 mM EDTA, 20 mM MES, pH 6.2. The record was ﬁltered at 30 Hz.
Figure 4. The effect of
trans antibody to CTX on
C-domain with a CTX stop-
per, and the dependence of
the effect on the turn-on volt-
age. Before the start of the
record, 9 ng of C-domain with
a CTX stopper and without a
His6-tag were added to the cis
compartment. Normal gat-
ing was seen, with the con-
ductance turning on at  50
mV and off at  50 or  110
mV. At the arrow, 3  g of anti-
CTX antibody were added to
the trans compartment. Con-
ductance that was subse-
quently turned on at  50 mV
continued to turn off nor-
mally at  110 mV. With a turn-
on voltage of  70 mV, a small
amount of reverse turn-on de-
veloped at  110 mV. With a
turn-on voltage of  90 mV, a
substantial reverse turn-on
developed at  110 mV. Thus, the amino-terminal CTX stopper was accessible to trans antibody when a large turn-on voltage was used. The
solution on both sides of the membrane and the ﬁltering were the same as in Fig. 3. The membrane was reformed after the colicin addition
and before the start of the record; this apparently introduced a small amount of colicin to the trans side, as evidenced by the small
conductance at negative voltages at the beginning of the record. These channels washed away shortly after the antibody was stirred in.
(Similar effects of trans anti-CTX were observed in experiments without a reformed membrane.)T
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ments, mouse anti– -galactosidase mAb added to the
trans compartment did not affect channel gating.
In experiments with the CTX stopper, rabbit poly-
clonal anti-CTX added to the trans compartment caused
a “reverse turn-on” conductance at negative voltage simi-
lar to that described in the previous paragraph (Fig. 4)
(n   7). Interestingly, this effect did not develop if the
channels were turned on by small positive voltages ( 50
or  70 mV), but only if they were turned on at larger
positive voltages ( 90 to  110 mV) (Fig. 4). It appears
that large voltages are required for the translocation of
the CTX stopper. This observation is conﬁrmed in the
single channel conductance transition experiments de-
scribed in a later section. The addition of a control anti-
body (rabbit polyclonal anti-HA.11) to the trans com-
partment had no effect on channel gating.
Although these macroscopic experiments with anti-
body to His6 and CTX do not yield the kind of quantita-
tive data presented in the following sections, they
clearly establish that the translocation pathway is (or
can be made) large enough to accommodate peptide
U, our smallest stopper, and CTX, our largest stopper.
Single-Channel Analysis of Folded Stopper C-Domain Proteins
The three-dimensional structures of the four stoppers
that were attached to the end of colicin Ia C-domain
are depicted in Fig. 2, A–D. Their diameters range
from 12–26 Å. The colicin Ia C-domain proteins, with
their amino-terminal stoppers, were added to planar
bilayers, as described in materials and methods.
Fig. 5 shows representative single-channel records from
these experiments. Channels formed by C-domains
with the 12- and 15-Å-diameter amino-terminal stop-
pers (peptide U and  -conotoxin, respectively) opened
in the normal-conductance state and rapidly dropped
to the small-conductance state (Fig. 5, A and B), indi-
cating that these stoppers are readily translocated at
 50 to  70 mV. Channels formed by C-domain with
the 19-Å-diameter amino-terminal stopper (apamin)
occasionally, and after considerable time, dropped
from the normal to the small conductance state at
 70 mV (Fig. 5 C). Channels formed at  70 mV by
C-domain with the 26-Å-diameter amino-terminal stop-
per (CTX) remained locked in the large conductance
state (unpublished data). Fig. 6 shows more systemati-
cally the effect of stopper size on the transition rate at
 40 mV. Each curve is a survival plot from a single ex-
periment, showing the percentage of channels whose
dwell time in the normal-conductance state was greater
than the time plotted on the abscissa (see materials
and methods). In most cases, the distribution of dwell
times for a given condition is ﬁt by a sum of two expo-
Figure 5. Representative single-chan-
nel records for C-domain with different
amino-terminal stoppers. (A) With a
12 Å stopper (peptide U), channels readily
made transitions to the small-conduc-
tance state. Three channels in succes-
sion opened at  70 mV with approxi-
mately normal conductance (33–42 pS)
and dropped to the small-conductance
state (each 8 pS), as noted by the ar-
rows. The second channel made its
transition quickly, so that on the slow
time scale of the ﬁgure the normal-con-
ductance state appears as a brief spike.
(B) With a 15-Å stopper ( -conotoxin),
channels also made transitions readily.
Of the ﬁve channels that opened at
 50 mV with normal conductance (39–
49 pS), four made transitions (at the ar-
rows) to the small-conductance state
(6–9 pS). (C) With a 19-Å stopper
(apamin), channels made transitions to
the small-conductance state very slowly
or not at all at  70 mV. Shown are
three channels, which opened at  70
mV with normal conductance (38–51
pS) (the second channel opened  2 s after the ﬁrst). After more than 4 min at this level, one of the channels dropped in conductance by
32 pS, as noted by the arrow, to a small-conductance state. The other two channels did not make transitions during the record. (D) With a
26-Å stopper (CTX), it was necessary to go to  90 mV to see conductance transitions at an appreciable rate. The record shows two channels
that opened quickly at  90 mV with normal conductance (60–63 pS). After long delays (4–14 min), each channel made a transition
(noted by the arrows) to a small-conductance state (14–16 pS). Solutions were the same as described in Fig. 1. The amount of stopper–
C-domain protein added to the cis solution for each experiment was as follows: A, 3.4 ng; B, 44 ng; C, 90 pg; D, 2 ng. In each of the
records, channels also made brief transients to a high-conductance state (60–70 pS above the normal-conductance level); these events are
not considered in this paper. Animals are as described in Fig. 2.T
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168 Sizing a Protein Translocation Pathway
nential components. Plots are shown for C-domain
without a stopper and with the peptide U,  -conotoxin,
and apamin stoppers. These plots conﬁrm our initial
judgment that, at a given voltage, larger stoppers make
slower transitions than do smaller stoppers.
From these experiments at voltages up to  70 mV, it
would appear that the translocation pathway for the
amino terminus is  19 Å wide at its narrowest part and
that the 26-Å-diameter CTX, like the much-larger
streptavidin discussed in the introduction, cannot
pass through the transmembrane passageway. This con-
clusion, however, is erroneous. The translocation rate is
strongly voltage dependent, so that although at  70
mV it appears that the apamin stopper reluctantly
crosses the membrane and the CTX stopper does not
cross at all, at larger voltages, both of these stoppers
readily cross the membrane (Figs. 5 D and 7). Fig. 7
presents survival plots for the four stoppers at several
different voltages. These plots show unambiguously
that all of the stoppers make faster transitions at larger
positive voltages (n   2–3 for each stopper). Perhaps
the most dramatic illustration of the voltage depen-
dence is for the apamin stopper (Fig. 7 C): at  110 mV,
all 25 channels made transitions in  25 s, whereas at
 40 mV, only 1 channel out of 36 made a transition in
 600 s.
Just as we had observed for C-domain without a stop-
per (Kienker et al., 2000), it is also true with a stopper
that the small-conductance state is stable, in the sense
that small channels do not revert to the normal-con-
ductance state while the positive voltage is maintained.
At a sufﬁciently large negative voltage, the small chan-
nels can be driven back to the original closed state (i.e.,
with the amino terminus back on the cis side), often
passing through some higher-conductance states on
the way. Although we have not systematically studied
the closing rate, it is clearly voltage dependent, being
quite slow (several minutes) at  50 mV and fast (sec-
onds) at  200 mV.
We have shown previously that binding streptavidin
near the amino terminus of C-domain prevents the
transition to the small-conductance state at  50 mV
(Kienker et al., 2000); that is, the streptavidin “stopper”
is not translocated. In light of the strong effect of volt-
age on the transition rate of the other stoppers, we re-
peated the streptavidin experiments at larger voltages.
C-domain with a biotin near the amino terminus and
without a His6-tag was incubated with streptavidin, and
unbound C-domain was then removed using a sizing
column (see materials and methods). This ma-
terial was added to the cis compartment in a bilayer ex-
periment. Seven channels were each held at  110 mV
for over an hour without making any transitions to the
small-conductance state (unpublished data) (n   5).
(At  120 mV, the channels began to slowly inactivate—
that is, to enter a completely closed state—so we were
unable to use larger voltages.) Results with avidin-
bound C-domain were similar, but were more difﬁcult
to analyze due to a slow “blocking” and “unblocking” of
the channels (n   5). So, at least at voltages up to  110
mV, the 61-Å-diameter streptavidin and avidin stoppers
cannot be translocated.
Effect of Unfolding the Stoppers
The validity of the above results, and hence the conclu-
sion about pathway width drawn from them, is predi-
cated on two assumptions: (1) that these stoppers,
which we claim traverse the membrane, are internally
disulﬁde bonded and therefore have the conforma-
tions depicted in Fig. 2; and (2) that the slower rates (at
a given voltage) at which the large diameter stoppers
(CTX and apamin) traverse the amino-terminal trans-
location pathway are a consequence of steric con-
straints, rather than being due to some property intrin-
sic to their sequences, such as their numerous positive
charges. The following results address these issues.
We have removed any detectable C-domain mole-
cules having free –SH groups in their stoppers (mate-
rials and methods). Presumably, therefore, the mole-
cules that we tested on the bilayers all had the internal
disulﬁde bonds formed in their stoppers, with the ex-
Figure 6. The effect of stopper size on the transition rate of
C-domain channels at  40 mV. Survival plots, each from a single
membrane, show the distribution of dwell times in the normal-
conductance state before a transition to the small-conductance
state. Each curve is ﬁt by a sum of two decaying exponential com-
ponents, with time constants  1 and  2 and amplitudes A and
(100%     A), respectively. The exception is the apamin curve,
which is ﬁt by a single exponential. n is the number of channels
measured. No stopper,  , n   47,  1   2.5 s,  2   38 s, A   73%.
Peptide U stopper,  , n   19,  1   46 s,  2   980 s, A   37%.
 -Conotoxin stopper,  , n   28,  1   34 s,  2   1200 s, A  
30%. Apamin stopper,  , n   36,     18000 s. Transitions are fast-
est with no stopper, and become progressively slower as larger
stoppers are used. Solutions were the same as described in Fig. 1.T
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ception of minor contamination from dimers and
higher multimers. As conﬁrmation of both this and the
validity of our entire approach, we found that when
these disulﬁde bonds were reduced, thereby unfolding
the stoppers, it became easier for them to traverse the
pathway, as evidenced by the shortening of dwell times
in the normal-conductance state. Fig. 8 shows an exam-
ple of this. Several minutes after the addition of the dis-
ulﬁde-reducing agent TCEP, the transition rate from
the normal-conductance to the small-conductance state
of C-domain channels with the amino-terminal peptide
U stopper signiﬁcantly increased (n   4). The effect of
reduction was particularly pronounced on C-domain
channels having the amino-terminal apamin stopper
(Fig. 9), which has two disulﬁde bonds (n   6). Prior to
TCEP addition, the dwell times in the open state at
 70 mV were of the order of minutes, whereas follow-
ing reduction they were merely several seconds or
shorter.
In the case of CTX, it is not possible to reduce its
three disulﬁde bonds by simple TCEP treatment at
room temperature, as was done for the other stoppers.
However, it is known that incubating the toxin for 10
min at 70 C in 10 mM DTT reduces these bonds (Naini
et al., 1996). C-domain with its amino-terminal CTX
survived this treatment and produced channels that
now rapidly underwent the transition from the normal
to the small conductance state at  70 mV (Fig. 10)
(n    3), a voltage at which no transitions were ob-
served with unreduced CTX. Thus, unfolded CTX is
fully capable of traversing the translocation pathway for
the amino terminus.
Survival plots for the reduced  -conotoxin, apamin,
and CTX stoppers are shown in Fig. 7 B–D (  and  ).
In each case, the transition rate with the reduced stop-
per is faster than with the unreduced stopper, even
though more moderate voltages were used with the re-
duced stoppers. This conﬁrms that the unfolded, re-
duced stoppers can be translocated more easily than
the folded, unreduced stoppers.
DISCUSSION
We describe here a method of characterizing the size of
a translocation pathway for protein across a lipid bilayer
membrane. We attached a series of small peptides, held
Figure 7. Survival plots illus-
trating the effects of voltage
and disulﬁde bond reduction
on the transition rate of
C-domain with each of the
peptide stoppers. Each curve
represents a series of dwell
times measured at the same
voltage. The measurements at
different voltages for a given
unreduced stopper are all
from a single membrane; the
measurements for each re-
duced stopper were obtained
on a different single membrane.
Unreduced stoppers:  ,  40
mV;   ,   90 mV;  ,   110
mV. Reduced stoppers:  ,
 70 mV;  ,  80 mV. Param-
eters have the same meanings
as described in Fig. 6. The
data at  40 mV in A, B, and C
are the same as described in
Fig. 6, so the ﬁtting parame-
ters are not repeated here.
(A) Peptide U.  90 mV, n  
41,     6.33 s. (See Fig. 8 for
the effect of disulﬁde bond
reduction.) (B)  -Conotoxin.  90 mV, n   36,  1   2.6 s,  2   38 s, A   63%.  70 mV, reduced, n   20,  1   0.07 s,  2   24 s, A   71%.
(C) Apamin.  90 mV, n   10,  1   8 s,  2   44 s, A   37%.  110 mV, n   25,  1   0.1 s,  2   5.6 s, A   12%.  70 mV, reduced, n   30,
 1   0.045 s,  2   8 s, A   84%. The  90 mV apamin data may be biased toward shorter dwell times, because several transitions that
occurred with multiple open channels in the normal state were excluded from the analysis. (D) CTX. Note the change of scale at the
break in the time axis.  90 mV, n   15,  1   7 s,  2   440 s, A   32%.  110 mV, n   28,  1   1.3 s,  2   35 s, A   35%.  80 mV, reduced,
n   9,  1   0.19 s,  2   2 s, A   64%. For all of the stoppers, the rate of transition to the small-conductance state is conspicuously voltage
dependent, with faster transitions at larger positive voltages. Disulﬁde bond reduction, which allows the stoppers to unfold, also greatly
increased the transition rates. For the folded stoppers, the solutions were the same as described in Fig. 1; for the unfolded stoppers, both
the cis and trans solutions also contained 1–20 mM TCEP.T
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170 Sizing a Protein Translocation Pathway
in a ﬁxed conformation by one or more disulﬁde
bonds, very near the amino-terminus of the colicin Ia
channel-forming (C) domain, and found that all of
these stoppers, whose minimal diameters ranged from
12 to 26 Å (see materials and methods), crossed the
membrane. There was a strong voltage dependence to
their translocation, such that at  40 to  70 mV, the
larger stoppers crossed slowly, if at all; at  90 to  110
mV they crossed readily (Figs. 5–7). That the size of the
stoppers was the relevant parameter governing their rel-
ative rates of translocation in our experiments (rather
than some other factors, such as charge or speciﬁc
amino acid composition) was illustrated by the much
greater translocation rates after their unfolding by dis-
ulﬁde bond reduction (Figs. 7–10). The translocation
pathway is thus large enough to allow the passage of an
 -helix, or even a pair of  -helices packed together side
by side. In our earlier experiments with carboxy-termi-
Figure 8. Comparison of translocation rates of
peptide U stopper attached to C-domain before
and after disulﬁde bond reduction. Each record
shows many channels ( 20), which opened at
 70 mV with normal conductance and then
dropped to the small-conductance state. Records
with most of the channels opening at the begin-
ning of the voltage pulse were selected, so that the
rate of transition to the small-conductance state is
reﬂected in the decay of the current. (A) Chan-
nels formed by unreduced peptide U–C-domain
dwelled in the normal-conductance state for a rel-
atively long time (   200 s) before making the
transition to the small-conductance state. (B) Later in the same experiment, after TCEP was
added to reduce the disulﬁde bond in peptide U, channels made their transitions much more
quickly (   30 s). This demonstrates that the cysteines in the stoppers of the channels making
transitions in A were in fact disulﬁde bonded. The concentration of TCEP was 9 mM on the cis
side and 5 mM on the trans side. The transition rate increased markedly within a few minutes of
TCEP addition; trace B happens to begin 25 min after TCEP was added. Channels in the small-
conductance state could be closed by a brief pulse to  200 mV (not shown), after which they
were ready to reopen through the normal-conductance state in response to a subsequent posi-
tive voltage pulse. Thus, the population of channels in trace B is more or less the same as that in
trace A. The unicorn icon in B is reduced in size to indicate that a reducing agent was added.
Solutions were the same as described in Fig. 1, except that TCEP was added in B. The amount of
peptide U–C-domain added to the cis solution at the beginning of the experiment was 1.4 ng.
Figure 9. Comparison of apamin stop-
per translocation by C-domain before
and after disulﬁde bond reduction. (A)
Three channels formed by unreduced
apamin–C-domain opened at  70 mV
with normal conductance (42–43 pS)
and made transitions to small conduc-
tance very slowly or, as in this record,
not at all. (B) Later in the same experi-
ment, after TCEP was added to reduce
the disulﬁde bonds in apamin, chan-
nels made rapid transitions (    1 s),
indicated by the arrows. The ﬁrst chan-
nel made its transition so quickly that
the transient, normal-conductance state
was not resolved. The concentration of
TCEP was 5 mM on both the cis and
trans sides. The transition rate in-
creased markedly within a few minutes
of TCEP addition; trace B happens to
begin 45 min later. Solutions were the
same as described in Fig. 1, except that
TCEP was added in B. The amount of
apamin–C-domain added to the cis so-
lution at the beginning of the experi-
ment was 3.6 ng.T
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nal fragments of colicin Ia (Kienker et al., 2000), it is
therefore likely that all of helix 1 (residues 359–467)
was translocated as an  -helix. The R domain (residues
282–385) has a larger cross-section than CTX, however
(Wiener et al., 1997), so it must have been at least par-
tially unfolded in those experiments in which it moved
across the membrane at voltages up to  70 mV.
A possible concern about the sizes we have assigned
to the stoppers is that they may not be folded in the
conﬁgurations shown in Fig. 2. Although we are reason-
ably conﬁdent that we have removed stoppers with free
sulfhydryls (see materials and methods), it is possi-
ble that the pairing of the cysteines is different from
that in the native structures. The stoppers that were in-
serted genetically also have their ends constrained by
the rest of the molecule into which they were inserted,
and therefore may not fold as the free stopper peptides
do. This is obviously not a concern for peptide U,
which has only two cysteines. Nor is it a concern for the
recombinant, bacterially expressed CTX. Although it
has six cysteines, it has been shown to fold into its na-
tive conformation and block potassium channels in the
same way as the native scorpion toxin (Park et al.,
1991). It is conceivable that the  -conotoxin and apamin
stoppers, each of which has four cysteines, could have
formed nonnative disulﬁde bonds, in which case the
stopper diameters would be somewhat different from
those given. However, at least for apamin, it appears
that rather drastic alterations in the peptide sequence
are required to change the disulﬁde pairing (Volkman
and Wemmer, 1997).
In our description of the C-domain with its stoppers,
we have implied that the stoppers are located exactly at
the amino terminus. This is not precisely correct. After
removal of the amino-terminal histidine tags from the
expressed constructs, there remain ﬁve (in the case of
peptide U) or six (in the case of  -conotoxin and
apamin) residues amino-terminal to the stoppers. De-
pending on the details of the stopper structures (i.e.,
on the proximity of the amino and carboxy termini),
this short extension may lie next to the stopper during
translocation, in which case the effective diameter of
the stopper would be somewhat larger. The situation is
even more complicated with the CTX stopper, which
was not inserted genetically into the C-domain con-
struct, but rather was chemically linked to residue 439
of the colicin Ia C-domain (see materials and meth-
ods). Thus, CTX is attached via a linker near its own
middle to a residue six positions from the amino termi-
nus of the C-domain. Unfolding CTX by reducing its
disulﬁde bonds therefore yields a structure with consid-
erable branching near its amino terminus. Neverthe-
less, the translocation pathway is able to accommodate
its passage.
The distribution of dwell times of the channel at the
normal-conductance level (in the state with four mem-
brane-spanning segments) before undergoing a transi-
tion to the small-conductance level (the state with three
membrane-spanning segments) is ﬁt by two (conceivably
more) exponentials (Figs. 6 and 7), implying that the
channel has at least two normal-conductance open
states. This is seen for each of the stoppers and also for
the carboxy-terminal fragment 438–626, which lacks a
stopper (Figs. 6 and 7). It is our impression that a given
channel has only one normal-conductance open state—
it either always has a short dwell time distribution or al-
ways has a long dwell time distribution—so that the two
exponentials reﬂect two different channel populations.
Since we are dealing with one particular protein (for a
given stopper), this is somewhat surprising. One possibil-
ity is that a given molecule associated with the bilayer
can be locked into two or more particular conﬁgurations
that are not readily interconvertible. For instance, differ-
ent colicin molecules might have the proline at residue
566 (the only proline residue in the C-domain) in either
the cis or the trans isomer, with the resulting channels
having different conformations. Further work is re-
quired to clarify this issue.
Figure 10. Fast translocation of re-
duced CTX stopper by C-domain. (A
corresponding experiment with unre-
duced CTX is shown in Fig. 5 D.)
CTX–C-domain was reduced as de-
scribed in materials and methods
before 100 ng of it were added to the
cis solution. The record shows ﬁve
channels, which opened at  70 mV
with normal conductance (37–39 pS),
and quickly dropped to the small-con-
ductance state (6–8 pS), as highlighted
by the arrows. Both the cis and trans
solutions contained 1.0 mM TCEP to
keep the sulfhydryl groups reduced. In this experiment, 10  g of octylglucoside were added to the cis solution to promote channel
activity, but in general, channels and transitions could be observed without octylglucoside. Solutions were the same as described in Fig.
1, except for the addition of TCEP.T
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Voltage Dependence of Translocation Rate
A striking characteristic of the stopper translocation ki-
netics we measured is their strong voltage depen-
dence—the larger the positive voltage, the more rapid
the translocation (Fig. 7). The mechanism of this volt-
age dependence is not clear. Given the positive charge
of the conotoxin, apamin, and CTX stoppers, an obvi-
ous explanation is a simple electrophoretic effect. This
cannot explain, however, the same sort of voltage de-
pendence seen with the peptide U stopper, which car-
ries a negative charge. A possible mechanism is that the
applied electric ﬁeld is acting directly on the transloca-
tion pathway and affecting its size. Thus, the diameter
of this pathway may not be ﬁxed, but rather may be a
function of the applied transmembrane potential. Such
an effect of potential is seen on the size of lipid pores
(Abidor et al., 1979; Chernomordik et al., 1983). A fea-
ture of this type of mechanism is that large voltages of
either sign should increase the pore diameter and, in
our case, increase the translocation rate. (Because the
normal-conductance channels rapidly turn off at nega-
tive voltages, this aspect of the mechanism is difﬁcult to
test. We are presently attempting to design experiments
that get around this problem.) There is also evidence
for protein translocation pores with a variable diameter
in the endoplasmic reticulum translocon (Hamman et
al., 1997, 1998) and the mitochondrial inner membrane
(Schwartz and Matouschek, 1999).
Comparison with Other Protein Translocation Pathways
The sizes of various conducting channels have been es-
timated in countless studies, dating to antiquity (Hille,
1971); some of these channels are permeable to large
molecules, such as polyethylene glycols and single-
stranded nucleic acids (Bezrukov, 2000). In what fol-
lows, however, we shall restrict our discussion to pores
or other pathways whose function is to allow proteins to
cross a membrane.
Self-inserting translocators. Several bacterial protein
toxins consist of a toxic enzymatic domain that is at-
tached (usually covalently) to a domain that is responsi-
ble for translocating the enzyme across a lipid mem-
brane into the cytosol of the target cell, where it exerts
its toxic effect. In many cases, the translocation domain
has been shown to form a conducting channel, raising
the possibility that the enzyme might be translocated
through the channel.2 For both diphtheria toxin (Oh
et al., 1999) and botulinum neurotoxin (Koriazova and
Montal, 2003), no additional proteins are required for
translocation across planar lipid bilayers. Interestingly,
the membrane topology of the diphtheria toxin chan-
nel is similar to that of the colicin Ia C-domain small
channel (Kienker et al., 2000; Senzel et al., 2000). An-
thrax toxin also makes a channel and translocates two
separate enzymes; there is indirect evidence from pla-
nar bilayer experiments that they may be translocated
through the conducting channel (Finkelstein, 1994).
Most likely, the enzymatic domains of these toxins are
translocated in an unfolded conformation (Wesche et
al., 1998), so that the sizes of their translocation path-
ways are not clear.
Other translocation domains may transport their pas-
senger domains in a folded conformation. The bacte-
rial autotransporters constitute one class of such pro-
teins, in which one domain is thought to export an-
other domain across the bacterial outer membrane by
forming a  -barrel pore through which the passenger
domain passes (Henderson et al., 1998). One example
is the IgA protease of Neisseria gonorrhoeae, whose pore
domain is capable of exporting an attached passenger
protein containing two disulﬁde bonds. As we have
shown here for colicin Ia C-domain, the passenger pro-
tein was translocated more readily in its reduced state,
but there was, nevertheless, signiﬁcant transport of the
unreduced, folded protein (Veiga et al., 1999). An-
other autotransporter, Antigen 43 of Escherichia coli, can
export a separate passenger protein containing a disul-
ﬁde bond (Kjærgaard et al., 2002). Streptolysin O be-
longs to another class of bacterial proteins that form
conducting channels. It seems that its main function is
to translocate the enzyme NAD-glycohydrolase across
eukaryotic cell membranes (Madden et al., 2001). If
the large (300-Å) pores visualized by electron micros-
copy (Palmer et al., 1998) represent the functional
channel, then the 52-kD enzyme could easily be trans-
located as a folded protein. Finally, the bacteriophage  
holin protein forms a pore in the inner membrane of
the target bacterium that allows the passage of an en-
dolysin protein. The puriﬁed holin is sufﬁcient to cause
calcein release from liposomes (Smith et al., 1998). In
vivo, endolysin fused to  -galactosidase can still pass
through the holin pore; it was argued that the  -galac-
tosidase portion was translocated as a folded tetramer
of 480 kD (Wang et al., 2003).
For most, if not all, of these proteins, the detailed
mechanisms of protein translocation have not yet been
elucidated; thus, it remains to be seen whether any of
them (with the possible exception of diphtheria toxin)
operates by a mechanism similar to that of colicin Ia.
Endogenous translocation pathways. There have been
many studies of protein translocation across eukaryotic
intracellular and bacterial membranes (for review see
Schnell and Hebert, 2003). Probably the most ex-
tensive studies on the size of a translocation pore
2This may be contrasted with the channel-forming polyene-like anti-
biotic monazomycin, in which the whole molecule both participates
in an oligomeric channel and is subsequently translocated (Heyer et
al., 1976).T
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have been on the protein import channel of the mito-
chondrial outer membrane. It has been shown that
branched polypeptides (Vestweber and Schatz, 1988b)
and a protein loop (Wiedemann et al., 2001) can be
imported into mitochondria. A gold cluster 20 Å in di-
ameter can also be imported, whereas a 26-Å cluster
cannot (Schwartz and Matouschek, 1999). Bovine pan-
creatic trypsin inhibitor, which contains three disulﬁde
bonds, is not imported (Vestweber and Schatz, 1988a);
its minimal diameter is  30 Å. Furthermore, the im-
port of dihydrofolate reductase ( 40–50 Å) is blocked
when its folded state is stabilized by the binding of
methotrexate (Eilers and Schatz, 1986). Thus, proteins
can pass through the outer membrane as an extended
strand or as a hairpin, but folded proteins are not nor-
mally imported (Schwartz et al., 1999).
Another well-characterized pore is the translocon of
the endoplasmic reticulum. Its diameter has been esti-
mated to be 40–60 Å when the ribosome is bound
(Hamman et al., 1997) and 9–15 Å in the ribosome-free
state (Hamman et al., 1998). Despite the large diame-
ter of the ribosome-bound pore, it appears that nascent
secretory proteins traverse the membrane in an ex-
tended,  -helical form (Plath et al., 1998).
There are also pores in cell membranes that translo-
cate folded proteins such as those we have used in this
study (and even larger proteins). Proteins in the endo-
plasmic reticulum can be transported back to the cyto-
sol, a process termed dislocation. It has been shown
that folded dihydrofolate reductase can be dislocated,
indicating that the translocation pathway has a diame-
ter of at least 40 Å (Tirosh et al., 2003). The twin-argi-
nine translocation (Tat) system of bacteria apparently
functions principally to move proteins that bind cofac-
tors, and thus must fold in the cytoplasm, across the in-
ner bacterial membrane. The Tat apparatus can trans-
locate proteins as large as the formate dehydrogenase-N
GH subcomplex, indicating a diameter of at least 60–70 Å.
(Berks et al., 2000; Palmer and Berks, 2003). However,
unlike colicin Ia, diphtheria toxin, and botulinum neu-
rotoxin, which are believed to be monomeric, these
translocation pores are large, multimeric complexes.
Thus, their structures are unlikely to explain how the
colicin translocates protein.
On the Structure of the Translocation Pathway
The translocation pathway followed by the amino-ter-
minal stoppers is probably not identical to the ion-con-
ducting channel. The diameter of the conducting
channel has been estimated in two ways: by the size of
ions that can pass through the narrowest part of the
channel and by the size of nonelectrolytes that can ﬁt
into some part of the channel. No upper limit has been
determined from the ion permeation experiments, but
a lower limit of 8–9 Å has been established for colicins
E1, A, and Ib (Raymond et al., 1985; Bullock et al.,
1992; Bullock and Kolen, 1995), and 7–8 Å for colicin
Ia, based on its permeability to bis-tris propane and tet-
raethyl ammonium (Jakes et al., 1999; Slatin and Kien-
ker, 2003). From the experiments using nonelectro-
lytes, it was concluded that the cis and trans entrances
of the colicin Ia channel are  18 and 10 Å in diam-
eter, respectively, with a 7-Å constriction in between
(Krasilnikov et al., 1998). It is hard to see how any of
our stopper peptides (12–26 Å) could ﬁt through such
a pore. Alternatively, one might expect that a stopper
would follow C-domain helix 1, to which it is attached,
through the membrane; that is, the space normally oc-
cupied by helix 1 would serve as the translocation path-
way. Conceivably, the smaller stoppers (12–15 Å) could
ﬁt through such a pathway, although they would pre-
sumably be exposed to lipid. By combining the helix 1
space with the conducting channel, we might get a
large enough pathway for apamin (19 Å) to pass
through the membrane. But even this combined path-
way is apparently much too small to allow the CTX
stopper (26 Å) to be translocated, unless the diameter
of the conducting channel has been substantially un-
derestimated.
We have not addressed the question of what kind of
structure of three transmembrane segments, formed
from   85 amino acid residues, could mediate the
translocation of a passenger as large as the 26-Å CTX.
This question is made more problematic by the fact
that the colicin channel appears to be a monomer,
based on the linear dependence of channel formation
on colicin concentration, as well as on the colicin’s mo-
nomeric state in aqueous solution above pH 4. (See Ca-
vard et al., 1988; Levinthal et al., 1991; Mel and Stroud,
1993; and references therein.) A similar problem exists
in the case of the diphtheria toxin T-domain, whose
channels appear to be monomeric based on the num-
ber of site-speciﬁc chemical reactions (one) observed
on single channels and on the absence of hybrid chan-
nels formed from mixtures of mutant T-domains with
distinct gating properties, as discussed by Gordon and
Finkelstein (2001). Thus, the only real evidence for a
multimeric channel is common sense: how could such
a small amount of protein possibly make such a large
channel? Although we have no model for the channel
structure, it is not unlikely that lipid is involved in the
translocation pathway (and in the conducting channel,
for that matter).
There is experimental evidence of interaction of
both secretory proteins and integral membrane pro-
teins with lipids adjacent to the proteinaceous translo-
con pore (Martoglio et al., 1995; Mothes et al., 1997;
Plath et al., 1998; Heinrich et al., 2000). Since these
studies also found interaction of the signal sequences
of these proteins with the Sec61 protein, the pathwayT
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for protein export in eukaryotes appears to involve
both protein and lipid.
It has been reported that a number of “protein trans-
duction domains” are internalized by cells, without the
involvement of receptors, transporters, or endocytosis,
and that attached proteins and other objects are also
carried across the membrane. These domains include
relatively short, very basic sequences from the Drosoph-
ila Antennapedia transcription factor, the HIV-1 TAT
protein (not to be confused with the bacterial Tat path-
way discussed above) and herpes simplex virus-1 DNA-
binding protein VP22 (Schwarze et al., 2000). It was hy-
pothesized that the Antennapedia domain may translo-
cate itself and an attached passenger by inducing the
formation of an inverted micelle in the membrane
(Derossi et al., 1996), and likewise for the HIV TAT do-
main (Vivès et al., 1997). It is tempting to consider this
as a model for translocation of stoppers by the colicin
C-domain. However, evidence in favor of the transloca-
tion of ﬂuorescently-labeled Antennapedia domain in
pure lipid bilayers (Thorén et al., 2000) has been bal-
anced by contrary evidence (Drin et al., 2001a,b). It has
also been reported that labeled HIV TAT domain does
not translocate into liposomes (Krämer and Wunderli-
Allenspach, 2003). Furthermore, there has recently
been some discussion as to whether the HIV TAT and
VP22 domains are truly able to efﬁciently carry cargo
across cell membranes (Falnes et al., 2001; Lundberg
and Johansson, 2002; Leifert et al., 2002; Richard et al.,
2003; Krämer and Wunderli-Allenspach, 2003).
Other models for a transmembrane pore lined by
protein and lipid have been proposed (for review see
Gilbert, 2002). Streptolysin O, whose role as a translo-
cation pore was discussed above, has been reported to
form large circular pores lined by oligomerized protein
in erythrocyte membranes, as visualized by electron mi-
croscopy. Mixing of native streptolysin O with a modi-
ﬁed, oligomerization-deﬁcient mutant resulted in hy-
brid oligomers that formed pore structures partially
lined by an arc of protein, with the remainder appar-
ently lined by a straight boundary of lipid (Palmer et
al., 1998). Presumably, the lipid head groups face into
the pore. As evidence for the functional relevance of
these structures, the hybrid pores appeared to have a
smaller size cutoff for permeant solutes than the native
pores. A somewhat different model comes from experi-
mental and theoretical studies of antimicrobial pep-
tides such as magainin, tachyplesin, and melittin (Mat-
suzaki, 1999; Lin and Baumgaertner, 2000; Huang,
2000; Yang et al., 2001; Zemel et al., 2003). In this pic-
ture, the insertion of the peptides into the membrane
destabilizes the packing of the bilayer lipids, inducing
them to form a toroidal structure, with the peptide
monomers separated from one another by lipid. Simi-
lar principles may be at work in the induction by
polypeptides of lipidic fusion pores (Basañez, 2002).
Perhaps the passageway that colicin Ia C-domain cre-
ates for its ﬁrst transmembrane segment (helix 1) and
the amino-terminal stoppers we have attached will turn
out to have a similar architecture, with the difference
that the membrane-spanning segments of the colicin
are tethered together by the extramembrane segments.
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